HearingAssist Eaze vs Otofonix Groove

The HearingAssist Eaze is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.4/5 in our lab testing. At $399, it sits in the most affordable price tier of the OTC market, though it ranks #43 of 65 devices in its category. In our standardized testing, the Eaze demonstrates excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling during typical daily activities. However, the device shows limitations in other areas: speech clarity scores are mixed at 2.6/5 in quiet and low at 1.3/5 in noisy environments, both falling slightly below category averages. The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average. Buyers who prioritize phone streaming for music or media should consider alternatives. Own-voice comfort is also mixed at 2.2/5, approximately 0.31 points below average for OTC devices. At this price point, shoppers have several higher-scoring alternatives to consider, including the Elehear Beyond and Apple AirPods Pro 2, which offer stronger overall performance. The HearingAssist Eaze may suit budget-conscious buyers who prioritize feedback stability over streaming capabilities and can accept modest speech performance in challenging listening situations.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.